the hope is to eventually get them to market---by the time the "dust settles" on all the hoops (clinical trials) that will have to be over come its probably better to stay on the sidelines for time being
I've owned CTIX ~4 years and have consistently added--BUT I'm tired of the lousy pps-I have my doubts Leo is going to be able to bring all three projects (Prurisol, Brucilidin, Kevetrin) to market unless he gets a partner with "deep pockets"---I'm glad you're adding but what kind of "time horizon" are we talking about (in your opinion) before the pps starts to improve?
followed their advice and LOST big time!!! worst service I've ever come across---unless you want to lose money
what were you expecting??? a "universal cure" for psoriasis??? the results were very good (dosing seems to be the only issue here and will be sorted out in phase 3)--there were no major side effects which is also better than ortezia or anything else out there-I can't believe the "market" is so stupid
I lost with every pick they suggested--their advise is GARBAGE!! you can do better picking stocks by throwing darts at a financial page
they need to team up with In Vivo therapeutics which is developing a polymer scaffold that has resulted in 4/6 ASIA-A to at least ASIA-B conversions in human spinal cord injured trial patients. In the long run stem cells alone won't work as well as stem cells + scaffold will
Followed ExplosiveOTC- and essentially "lost my shirt" on some of their stupid recommendations--they represent the "vermin" of stock advice services
are you "hedging your bet" and buying STEM too? if this story is about STEM (no where does it mention STEM but the results are quite impressive---if the scaffold was added to the treatment I bet they would be even more remarkable-so I hope NVIV can strike a partnership with STEM)
They didn't mention the company---was it STEM? looked up the story--couldn't find anything about the company (knew it wasn't CUR)
Leo also promised in press releases that CTIX would be uplisting to the NASDAQ "shortly"---nothing came of that--so I remain nervous about the prurisol results especially since most of his attention seems to be focused on Kevitrin and Brucilidin--Prurisol almost seemed like an "afterthought"
In a previous article Jason Napadono stated that In Vivo approached CUR about a partnership and was told by CUR management that "we don't need a scaffold"--that decision is going to come back to haunt CUR (and I still don't understand how just "plunking" stem cells into a site is going to result in any benefit anyway--without an "anchor" (like what is provided by the scaffold) stem cells can't survive in a hostile environment--maybe that why CUR is "tanking" now?)
with only one more conversion needed to meet the FDA requirement of 25% success (and with patient #7 likely to be that conversion) your comment is beyond doubtful
I would never give Feurerstein "kudos" for anything--he's a disgusting weasel who makes unfounded claims/ criticisms of stocks to manipulate their pps. He's been attacking NWBO, MNKD and most recently AVXL for that said purpose. I hope ultimately he's brought before the SEC--he's got some serious explaining to do
Anavex 2-73 'significantly' reduced number of spasms in an animal model with infantile spasms in infant rats
I completely believe in the science behind A-273 and have been long with AVXL (back when it was $0.25 pps) but the scientific "universe" is full of examples of drugs that have worked well in animals but ultimately failed in humans. Until the human trials get going results like these (although promising) aren't going to do much for the pps or attracting more investor interest
I work as an internist in a hospital and have to deal with C Diff infections all the time. We are now even doing fecal transplants to try and get these infections under control when antibiotics (flagyl/vancomycin) don't work. If SYN-004 works this will be a ++++billion dollar drug---CDiff infections kills thousands of people annually (especially the elderly and immunosuppressed patients)--the FDA should "fast track" this ASAP
you keep posting this #$%$ and I'll keep reporting you---I want nothing to do with some two bit stock service--what are they paying you moron to post this garbage
I believe strongly in the science behind A-273 and have personally lost grandparents to the ravages of dementia---I'm disgusted by some oft these moronic bashers (ie. Feurerstien etc) but this Motley Fool article seems to make some valid points---I'm worried about financing as we go forward and whether the company is working aggressively enough to find a partnership----anyone else have the same concerns??
will you be adding to your position?? would seem to be the ideal time before this settlement is made official--and what do you think the potential pps is when the announcement of this settlement is made? thanks for your posts
none the less you would think with this news and how low the pps there would be alot of investors "jumping on board"---not that I mind since this gives me the chance to add more at this price (I think any risk now has been eliminated)